Devin D. Bolz

478 total citations
10 papers, 363 citations indexed

About

Devin D. Bolz is a scholar working on Infectious Diseases, Immunology and Genetics. According to data from OpenAlex, Devin D. Bolz has authored 10 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Immunology and 4 papers in Genetics. Recurrent topics in Devin D. Bolz's work include Antimicrobial Resistance in Staphylococcus (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Vector-borne infectious diseases (3 papers). Devin D. Bolz is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (4 papers), Toxin Mechanisms and Immunotoxins (3 papers) and Vector-borne infectious diseases (3 papers). Devin D. Bolz collaborates with scholars based in United States, Japan and Germany. Devin D. Bolz's co-authors include Jennifer L. Tenor, Alejandro Aballay, Janis J. Weis, Rhianna S. Sundsbak, John H. Weis, Shizuo Akira, Ying Ma, James F. Zachary, Carsten J. Kirschning and Dennis L. Stevens and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

Devin D. Bolz

10 papers receiving 360 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devin D. Bolz United States 8 141 123 103 88 86 10 363
Brad Barrows United States 9 55 0.4× 59 0.5× 247 2.4× 52 0.6× 63 0.7× 23 409
Felicity E. Lumb United Kingdom 11 110 0.8× 214 1.7× 135 1.3× 89 1.0× 9 0.1× 14 384
Bastian Pasche Germany 12 48 0.3× 36 0.3× 185 1.8× 136 1.5× 9 0.1× 14 554
Patrick Driguez Australia 15 60 0.4× 416 3.4× 115 1.1× 29 0.3× 5 0.1× 26 572
M. K. Bhopale India 10 29 0.2× 170 1.4× 78 0.8× 84 1.0× 31 0.4× 27 392
Olivia L. McGovern United States 12 26 0.2× 226 1.8× 173 1.7× 15 0.2× 58 0.7× 13 475
Ji-Ae Kim South Korea 10 117 0.8× 12 0.1× 75 0.7× 98 1.1× 13 0.2× 11 351
Hongyu Qin China 10 51 0.4× 35 0.3× 159 1.5× 79 0.9× 3 0.0× 37 378
Stephen W. Eisinger United States 7 130 0.9× 121 1.0× 77 0.7× 83 0.9× 14 0.2× 7 335
S Dissanayake United Arab Emirates 11 231 1.6× 141 1.1× 47 0.5× 29 0.3× 7 0.1× 24 370

Countries citing papers authored by Devin D. Bolz

Since Specialization
Citations

This map shows the geographic impact of Devin D. Bolz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devin D. Bolz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devin D. Bolz more than expected).

Fields of papers citing papers by Devin D. Bolz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devin D. Bolz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devin D. Bolz. The network helps show where Devin D. Bolz may publish in the future.

Co-authorship network of co-authors of Devin D. Bolz

This figure shows the co-authorship network connecting the top 25 collaborators of Devin D. Bolz. A scholar is included among the top collaborators of Devin D. Bolz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devin D. Bolz. Devin D. Bolz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bolz, Devin D., et al.. (2019). Regulation of virulence and antibiotic resistance in Gram-positive microbes in response to cell wall-active antibiotics. Current Opinion in Infectious Diseases. 32(3). 217–222. 17 indexed citations
2.
Katahira, Eva J., Stephen M. Davidson, Dennis L. Stevens, & Devin D. Bolz. (2018). Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. Journal of Medical Microbiology. 68(2). 255–262. 15 indexed citations
3.
Hobdey, Sarah E., Eva J. Katahira, Stephen M. Davidson, et al.. (2017). Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureusIn Vitro. Antimicrobial Agents and Chemotherapy. 61(11). 4 indexed citations
5.
Bolz, Devin D., et al.. (2014). Cardiac Myocyte Dysfunction Induced by Streptolysin O Is Membrane Pore and Calcium Dependent. Shock. 43(2). 178–184. 26 indexed citations
6.
Parimon, Tanyalak, Zhi Li, Devin D. Bolz, et al.. (2013). Staphylococcus aureus α-Hemolysin Promotes Platelet-Neutrophil Aggregate Formation. The Journal of Infectious Diseases. 208(5). 761–770. 31 indexed citations
7.
Bolz, Devin D., Jennifer L. Tenor, & Alejandro Aballay. (2010). A Conserved PMK-1/p38 MAPK Is Required in Caenorhabditis elegans Tissue-specific Immune Response to Yersinia pestis Infection. Journal of Biological Chemistry. 285(14). 10832–10840. 105 indexed citations
8.
Bolz, Devin D., Rhianna S. Sundsbak, Ying Ma, et al.. (2006). Dual Role of MyD88 in Rapid Clearance of Relapsing FeverBorreliaspp. Infection and Immunity. 74(12). 6750–6760. 14 indexed citations
9.
Bolz, Devin D., Rhianna S. Sundsbak, Ying Ma, et al.. (2004). MyD88 Plays a Unique Role in Host Defense but Not Arthritis Development in Lyme Disease. The Journal of Immunology. 173(3). 2003–2010. 125 indexed citations
10.
Bolz, Devin D. & Janis J. Weis. (2004). Molecular Mimicry toBorrelia burgdorferi: Pathway to Autoimmunity?. Autoimmunity. 37(5). 387–392. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026